Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is
1. to determine the correct dose for intramuscular administration
2. to compare the frequency of antibody formation after intramuscular administration of
native E.coli asparaginase and PEG-asparaginase during two treatment courses in the
treatment of childhood lymphoblastic leukemia
Phase:
Phase 4
Details
Lead Sponsor:
Nordic Society for Pediatric Hematology and Oncology
Collaborators:
Danish Child Cancer Foundation Medac, Hamburg, Germany